SCHEDULE 13G/A
Statement of Beneficial Ownership
Stoke Therapeutics, Inc. Filed Acc 0001493215-26-000208
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| RTW Investments, LP | 6,537,475 | 9.9% |
| Roderick Wong | 6,537,475 | 9.9% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 9.9%
- 2026-11-16 SCHEDULE 13G/A · Baker Bros. Advisors LP 4.7%
- 2026-11-16 SCHEDULE 13G/A · Wellington Management Group LLP 7.3%
- 2026-11-13 SCHEDULE 13G/A · Morgan Stanley 4.9%
- 2026-08-12 SCHEDULE 13G/A · The Toronto-Dominion Bank 4.9%
- 2026-05-15 SCHEDULE 13G/A · The Toronto-Dominion Bank 5.4%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…